Publications

November 2011 (Revised February 2012)
Case

China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise

By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki

As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details

Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; China

April 2010
Teaching Note

Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics

By: Robert S. Huckman

Teaching Note for [607008]. View Details

Keywords: Restructuring; Decisions; Innovation and Invention; Research and Development; Pharmaceutical Industry; Pharmaceutical Industry

October 2009 (Revised July 2013)
Case

Gilead Sciences, Inc.: Access Program

By: V. Kasturi Rangan and Katharine Lee

Gilead Sciences, the U.S. leader in HIV/AIDS medicines, with global sales of $5.4 billion in 2009, had undertaken several innovative actions to make its anti-viral products available to over 100 low- and middle-income countries. Having reached nearly 680,000 patients... View Details

Keywords: Health Care and Treatment; Emerging Markets; Product; Sales; Competitive Strategy; Pharmaceutical Industry; Pharmaceutical Industry

March 2009
Teaching Note

Proteus Biomedical: Making Pigs Fly (TN)

By: Richard G. Hamermesh

Teaching Note for [809051]. View Details

Keywords: Business Startups; Information Technology; Competition; Negotiation Deal; Pharmaceutical Industry; Pharmaceutical Industry

June 2003 (Revised October 2004)
Case

Novartis: The Challenge of Success (D)

By: Sandra J. Sucher and Stacy McManus

Supplements the (A) and (B) cases. View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry

June 1999 (Revised June 2000)
Case

Eckerd Corporation

By: Michael E. Porter and John E. Kelleher

Describes the history and current situation in the retail pharmacy industry, including competition from new merchants and Internet drugstores. Eckerd, one of the top four drug chains, must decide how to position itself for the future. View Details

Keywords: Competition; Alignment; Supply and Industry; Pharmaceutical Industry; Pharmaceutical Industry

01 Sep 2015
Blog Post

Building a Startup at HBS

prototype which we showcased at HBS and tested out in the NICU to observe its efficacy and nurse uptake. While we each embarked on different paths after the end of first year– from launching a new healthcare venture in Africa, to working at large View Details

Fast Answer

Transforming Health Care Delivery

Books Books and journal titles on all aspects of the health care, life sciences and pharmaceutical sectors View Details

13 Jan 2003
Research & Ideas

Making Biotech Work as a Business

influenced the industry by proving that intellectual property could be monetized through alliances with big pharmaceutical partners, according to Pisano. Genentech cut its first deal with Eli Lilly in 1982 and new entrants were excited.... View Details

Keywords: by Martha Lagace; Biotechnology; Health; Technology

18 Aug 2017
Op-Ed

Op-Ed: Courageous Leader Triggers a Moral Revolt of CEOs Against Trump

actions was not without risk for the CEOs and their companies” While many CEOs prefer to stay under the radar and avoid public scrutiny, Ken Frazier led the way with his example. As the chair of PhRMA, the pharmaceutical manufacturers... View Details

Keywords: by Bill George

20 May 2013
Op-Ed

Making America an Industrial Powerhouse Again

talent pool in the US biomedical field that is second to none. And the only way to get that talent is for companies-both domestic and foreign-to do their R&D here. That's why pharmaceutical and biotechnology companies from around the... View Details

Keywords: by Gary Pisano; Manufacturing

23 Jul 2001
Research & Ideas

How Relationships are Building Biotech

on biotech companies in terms of securing resources. And if the top executives had a career background at a pharmaceutical and/or healthcare company—the companies considered "downstream" to biotech—so much the better. The IPO is... View Details

Keywords: by Martha Lagace & Mallory Stark

01 Apr 1999
News

Q & A: Confronting New Technologies: When Doing Right Is Wrong

industries or certain segments of the pharmaceutical business. But in many other industries - financial services, education, and health care, for instance - this analytical model is proving extremely helpful in understanding what is... View Details

01 Mar 2003
News

Inside the Revolution

care and life sciences issues, with the lion’s share focusing on the biotech and pharmaceutical industries. More than twenty HBS professors from different disciplines have contributed to this effort, which Pisano says is analogous to the... View Details

Keywords: Garry Emmons; Eileen McCluskey; Jonathan West; Life Sciences Project; LSP; Colleges, Universities, and Professional Schools; Educational Services

February 2001
Teaching Note

CVS: The Web Strategy TN

By: John A. Deighton

Teaching Note for (9-500-008). View Details

Keywords: Pharmaceutical Industry; Pharmaceutical Industry